Too Much Vitamin A: Symptoms, Doses and Who Is at Risk

Excess is easy to miss because labels use different units: micrograms of retinol equivalents (µg RE), micrograms of retinol activity equivalents (µg RAE) and old international units (IU). For retinol, 1 IU is taken to correspond to about 0.3 µg, so 3000 µg is about 10,000 IU. The recommended intake for adults according to various documents is roughly 700–900 µg a day — so the upper limit is several times higher than the requirement, but supplements and some foods can bring it close to or beyond it.

One important remark from EFSA: European populations are unlikely to exceed the limit for preformed vitamin A if consumption of liver and offal is limited to once a month or less. In other words, the risk is concentrated in three groups: regular consumers of liver, people taking several supplements at once (a multivitamin plus cod liver oil plus a 'skin' product), and patients treated with retinoids.

The European Food Safety Authority in its 2024 opinion proposes retaining the tolerable upper intake level (UL) of preformed vitamin A at 3000 µg RE a day for adults. It applies to men and women, including women of child-bearing age, pregnant and lactating women, and post-menopausal women. For other age groups the UL is scaled by body weight: from 600 µg RE a day for infants aged 4–11 months to 2600 µg RE for adolescents aged 15–17. Teratogenicity was selected as the critical effect, and hepatotoxicity and effects on bone were also assessed.

For beta-carotene EFSA did not set a UL, because the available data did not allow a dose-response relationship to be described, but it noted that there is no indication that beta-carotene from the diet is harmful. Lung cancer risk was selected as the critical effect of excess supplemental beta-carotene, so smokers should avoid supplements containing beta-carotene, and the general population should use them only to meet vitamin A requirements. The panel also noted that the data did not allow assessment of whether beta-carotene could potentiate toxicity of preformed vitamin A.

Poisoning occurs in two forms. Acute results from a single very large dose (hundreds of thousands of IU) and causes nausea, vomiting, headache, dizziness, double vision and signs of raised intracranial pressure. Chronic arises from long-term intake of doses above the limit, often over months or years, and is much more insidious, because symptoms build gradually and are easily mistaken for other diseases.

The liver is the target organ here. The review in the World Journal of Hepatology (Pestalardo et al., 2025) describes how the liver stores vitamin A in stellate cells; with excess, retinoids accumulate, with oxidative stress and inflammation, and changes progress from steatosis through fibrosis to cirrhosis. The authors point out the need for better biomarkers and more individualised risk assessment. We write about interpreting liver tests in our entry on ALT, AST and GGT.

A meta-analysis of prospective studies (Wu et al., 2014; 8 intake studies – 283,930 participants, 4 studies of blood retinol – 8725 participants) confirmed that high intake of vitamin A and retinol was associated with a raised risk of hip fracture (adjusted RR 1.29 and 1.40), while beta-carotene intake was not (0.82). Interestingly, both high and low blood retinol concentration increased risk (1.87 and 1.56), and the relationship was U-shaped; total fracture risk did not differ significantly. An earlier review by Penniston and Tanumihardjo (2006) noted that osteoporosis and hip fracture are associated with preformed vitamin A intakes only twice the recommended intake.

That is exactly why teratogenicity is the critical effect in EFSA's setting of the UL. The EFSA opinion states plainly that women planning pregnancy or who are pregnant should not eat liver products. In practice this also means caution with multivitamins and supplements containing retinol in high doses: prenatal preparations are chosen under the supervision of a doctor or midwife, and the retinol dose should not exceed the recommended level. Beta-carotene is not a problem here, because the body regulates its conversion into retinol.

Diagnosis of hypervitaminosis A rests above all on history (which preparations, how long, at what dose) and on symptoms. Serum retinol concentration alone is a poor indicator here: Penniston and Tanumihardjo (2006) point out that in the subtoxic and toxic range serum retinol is an insensitive indicator, because the body keeps it within a narrow range until liver stores are enormously exceeded. A retinol result 'within normal' therefore does not exclude excess in the liver, and doctors more often rely on liver tests, calcium and the clinical picture.

Management is usually simple, though it needs patience: stopping all sources of excess (supplements, liver, cod liver oil), checking the liver and calcium, and in hypercalcaemia hydration and supportive treatment under a doctor's supervision. After stopping, symptoms usually decrease, but the pace depends on the dose, the duration of the excess and the organ involved — skin, bone and liver changes resolve more slowly than acute symptoms. Do not use 'liver cleansing' products or high doses of other supplements on your own; treatment is chosen by the doctor.

If you take several supplements at once, add up the vitamin A from the labels (note whether it is given as retinol, retinyl palmitate or beta-carotene) and compare it with the limit of 3000 µg RE a day. Awareness of this sum alone often suffices to reduce the risk, and requires no tests.

To sum up: vitamin A is a classic example of a nutrient where 'more' can be worse than 'enough'. A simple calculation suffices: how much retinol comes from supplements, cod liver oil and liver, and whether the total approaches 3000 µg RE a day. The safest source is a varied diet with vegetables rich in beta-carotene; retinol supplements are taken when there is a clear indication. And in pregnancy and during retinoid treatment the rules are stricter than in other situations.